A Phase 1 Randomized, Placebo and Active Comparator-controlled Trial, Double-blind for the IPs, Observer-blind for the Active Comparator, to Assess the Potency of SOR007 (Uncoated Nanoparticle Paclitaxel) Ointment in a Psoriasis Plaque Test
Phase of Trial: Phase I
Latest Information Update: 17 Feb 2017
At a glance
- Drugs Paclitaxel (Primary) ; Betamethasone-dipropionate/calcipotriol
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors US Biotest Inc
- 14 Feb 2017 Status changed from active, no longer recruiting to completed.
- 31 Jan 2017 Status changed from recruiting to active, no longer recruiting.
- 10 Jan 2017 New trial record